External validation of nomogram to predict progression-free survival at 6 months (PFS6) in patients receiving salvage therapy for advanced urothelial carcinoma (UC).
Guru Sonpavde
No relevant relationships to disclose
Joaquim Bellmunt
Research Funding - Pierre Fabre Medicament
Ronan Fougeray
Employment or Leadership Position - Pierre Fabre Medicament
Yacine Salhi
Employment or Leadership Position - Pierre Fabre Medicament
Gregory Russell Pond
No relevant relationships to disclose